Originally approved in 2011 as an IV therapy for adults with SLE ... as the only biologic approved to treat SLE. Approval in lupus nephritis is expected to push the product above the $1 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback